List your tool

Head to head · 2026

Artera vs Manifold

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Artera

FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions

4.4Not listed

Visit Artera (opens Artera in a new tab)

Manifold

Enterprise agent platform for life sciences that cuts administrative burden in clinical research

4.0Not listed

Visit Manifold (opens Manifold in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Artera does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Artera

    4.4 against 4.0

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onArteraManifold
Our rating4.4Better4.0
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Multimodal AI trained on digitized biopsy images paired with clinical data
  • FDA De Novo authorization for the ArteraAI Prostate Test
  • FDA clearance for ArteraAI Breast digital pathology risk stratification
  • Results delivered in as little as two days after sample submission
  • Inclusion in National Comprehensive Cancer Network (NCCN) treatment guidelines
  • Study participant enrollment and engagement tools
  • Longitudinal clinical data harmonization and curation
  • Multimodal dataset discovery and analysis
  • Secure cross-organization collaboration
  • Administrative burden reduction for cancer center workflows
Pros
  • Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
  • Published clinical evidence showing improved outcome prediction versus existing risk models
  • Adopted by a meaningful share of US prostate cancer clinicians already
  • Founding team's Kyruus healthcare background informs a domain-specific product
  • $15 million Series A funding signals institutional confidence in the approach
  • Targets a concrete, high-cost problem in clinical research administrative burden
Cons
  • Not a self-serve software product; access runs through labs, clinicians, and insurance billing
  • Pricing is not public and varies by payer and region
  • Limited to prostate and breast cancer currently, not a general oncology platform
  • No published pricing available for budget comparison
  • Built specifically for life sciences and clinical research, not a general research tool
  • Enterprise sales cycle likely required before deployment
CompanyArtera, founded 2021Manifold, founded 2016

Prices come from each vendor's pricing page, last checked 20260802. Check the vendor before you buy.

FAQ

Questions people ask

Is Artera better than Manifold?

In our reviews Artera scores 4.4 and Manifold scores 4.0. The better pick depends on the job. Artera: FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. Manifold: Enterprise agent platform for life sciences that cuts administrative burden in clinical research.

Which is cheaper, Artera or Manifold?

Artera: see pricing. Manifold: see pricing.

Do Artera and Manifold have free plans?

Neither lists a free plan.

More comparisons

Artera compared with

All Artera alternatives

Manifold compared with

All Manifold alternatives